Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Interest Expenses (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Interest Expenses for 16 consecutive years, with $112942.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 49.41% to $112942.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $495990.0 through Dec 2025, down 18.09% year-over-year, with the annual reading at $495990.0 for FY2025, 18.09% down from the prior year.
  • Interest Expenses hit $112942.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $109699.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $223261.0 in Q4 2024 to a low of $20021.0 in Q3 2021.
  • Historically, Interest Expenses has averaged $122669.2 across 5 years, with a median of $122961.0 in 2022.
  • Biggest five-year swings in Interest Expenses: crashed 78.35% in 2021 and later soared 645.92% in 2022.
  • Year by year, Interest Expenses stood at $27734.0 in 2021, then soared by 547.06% to $179456.0 in 2022, then fell by 0.37% to $178792.0 in 2023, then rose by 24.87% to $223261.0 in 2024, then crashed by 49.41% to $112942.0 in 2025.
  • Business Quant data shows Interest Expenses for CPIX at $112942.0 in Q4 2025, $109699.0 in Q3 2025, and $109547.0 in Q2 2025.